Sentinel Lymph Node Detection in Prostate Surgery by Laparoscopy

NCT ID: NCT01296217

Last Updated: 2011-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study the investigators want to determine if the detection of lymph node is applicable in prostatectomy by laparoscopy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostatic Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

lymph nod detection

Group Type EXPERIMENTAL

lymph nod detection

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

lymph nod detection

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age\> 18 years
* Diagnosis of invasive cancer of the prostate (T1 or T2 or T3)
* PSA ≥ 4,
* Gleason ≥ 6
* No treatment prior to surgery
* Indication of lymphadenectomy by coeliscopique
* ECOG or Karnofsky index 2
* Patient information and signed informed consent

Exclusion Criteria

* neoadjuvant hormone therapy
* Interventions prior pelvic
* Patients who received anterior resection of part of prostate
* Patient or denied having an altered mental status
* Any contre indication to laparoscopy
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre René Gauducheau

OTHER

Sponsor Role lead

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre René Gauducheau

Nantes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BRD 07/11-M

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.